| Dr Susan Hoggard Wamble, DDS MS | |
|
1301 Ridgway Rd, Suite 2-b, Pine Bluff, AR 71603-7611 | |
| (870) 535-8600 | |
| (870) 535-1266 |
| Full Name | Dr Susan Hoggard Wamble |
|---|---|
| Gender | Female |
| Speciality | Dentist - Pediatric Dentistry |
| Location | 1301 Ridgway Rd, Pine Bluff, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376550038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 2996 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Hoggard Wamble, DDS MS 1301 Ridgway Rd, Suite 2-b, Pine Bluff, AR 71603-7611 Ph: (870) 535-8600 | Dr Susan Hoggard Wamble, DDS MS 1301 Ridgway Rd, Suite 2-b, Pine Bluff, AR 71603-7611 Ph: (870) 535-8600 |
News Archive
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Chapman University's four-year-old School of Pharmacy continues its aggressive growth in federal grant awards.
A study conducted by Richard Vander Heide, MD, PhD, Professor and Director of Pathology Research at LSU Health New Orleans School of Medicine, and Marc Halushka, MD, PhD, Professor of Pathology at Johns Hopkins University School of Medicine, suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.
A new Cedars-Sinai initiative called research for her is aimed at increasing women's representation in medical research, which could help scientists better understand and more effectively treat cancers that predominantly affect women.
Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.
› Verified 5 days ago
Dr. Charles Garrett Taylor Ii, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3721 S Olive St, Pine Bluff, AR 71603 Phone: 870-536-6917 Fax: 870-536-4404 | |
John Philip Mckenzie Davis, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4100 W 28th Ave, Pine Bluff, AR 71603 Phone: 870-879-4870 | |
Dr. William T Shepherd, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1242 W 42nd Ave, Pine Bluff, AR 71603 Phone: 870-535-0301 Fax: 870-535-5724 | |
Dr. John Williams Ross, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3721 Olive Street, Pine Bluff, AR 71603 Phone: 870-536-6917 Fax: 870-536-4404 | |
Michael D Clark, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1616 S Cherry St, Pine Bluff, AR 71601 Phone: 870-534-2151 | |
Dr. Maxwell U Fleming Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 3721 S Olive, Ste B, Pine Bluff, AR 71603 Phone: 870-536-9800 Fax: 870-536-9804 | |
Dr. Harry L. Ryburn, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4301 S Mulberry St, Suite A, Pine Bluff, AR 71603 Phone: 870-535-5616 |